Founded in 2004, Hangzhou HealthSky Biotechnology Co., Ltd. has been focusing on R&D, manufacturing, sales, and service in the field of Pathological Diagnosis for two decades.

HealthSky is committed to providing unique and advanced solutions for Cervical Cancer Screening and Histological Diagnosis.

Based on the deep understanding of Pathological Diagnosis and depending on the professional R&D team and the state-of-the-art facilities, HealthSky is on the way to making the process of Pathological Diagnosis more standard, automatic. intelligent, and precise.

HealthSky covers an area of 12,000 square meters, including the R&D Center, the standard Manufacturing Plant, and the accredited Pathology Diagnostic Laboratory. The Company now has more than 300 employees. More than 50 are R& D researchers, and 60% are with Ph.D. or Master's Degree.

Continuous innovation drives HealthSky forward. The Company has obtained 12 Invention Patents, 35 Utility Patents and 4 Software Copyrights.

Pathology, the bridge between science and medicine. HealthSky will keep striving for excellence, working for a healthier and brighter future for humans.